Clinical trials
Suspended trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 2 |
| 2014 | 1 |
| 2017 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 3 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Suspended | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| Emerald Health Pharmaceuticals | 2 |
| Beijing Inno Medicine Co., Ltd. | 1 |
| BioFirst Corporation | 1 |
| Boehringer Ingelheim | 1 |
| CStone Pharmaceuticals | 1 |
| Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | 1 |
| Helicore Biopharma, Inc. | 1 |
| Humanigen, Inc. | 1 |
| Monash University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 1 |
| Autoimmune Diseases of the Nervous System | 1 |
| Chronic Limb-Threatening Ischemia | 1 |
| Cognitive Dysfunction | 1 |
| Connective Tissue Diseases | 1 |
| Dementia | 1 |
| Glioma | 1 |
| Leukemia | 1 |
| Multiple Sclerosis | 1 |
| Multiple Sclerosis, Relapsing-Remitting | 1 |
Trials
Showing 51 to 18 of 18. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.